^
No biomarker
Mantle Cell Lymphoma
brexucabtagene autoleucel
Sensitive
:
A1
No biomarker
Mantle Cell Lymphoma
ICP-022
Sensitive
:
A1
No biomarker
Mantle Cell Lymphoma
lenalidomide
Sensitive
:
A1
No biomarker
Mantle Cell Lymphoma
zanubrutinib
Sensitive
:
A1
No biomarker
Mantle Cell Lymphoma
temsirolimus
Sensitive
:
A1
No biomarker
Mantle Cell Lymphoma
ibrutinib
Sensitive
:
A1
No biomarker
Mantle Cell Lymphoma
rituximab + bortezomib
Sensitive
:
A1
No biomarker
Mantle Cell Lymphoma
acalabrutinib
Sensitive
:
A1
No biomarker
Mantle Cell Lymphoma
venetoclax + ibrutinib
Sensitive
:
A2
No biomarker
Mantle Cell Lymphoma
rituximab
Sensitive
:
A2
No biomarker
Mantle Cell Lymphoma
bendamustine
Sensitive
:
A2
No biomarker
Mantle Cell Lymphoma
rituximab + lenalidomide
Sensitive
:
A2
No biomarker
Mantle Cell Lymphoma
bortezomib
Sensitive
:
A2
No biomarker
Mantle Cell Lymphoma
venetoclax
Sensitive
:
A2
No biomarker
Mantle Cell Lymphoma
rituximab + ibrutinib + lenalidomide
Sensitive
:
A2
ALK negative
Mantle Cell Lymphoma
brentuximab vedotin
Sensitive
:
A2
No biomarker
Mantle Cell Lymphoma
VR-CAP
Sensitive
:
A2
No biomarker
Mantle Cell Lymphoma
R-DHAP
Sensitive
:
A2
No biomarker
Mantle Cell Lymphoma
R-DHAX
Sensitive
:
A2
No biomarker
Mantle Cell Lymphoma
R-CVAD
Sensitive
:
A2
No biomarker
Mantle Cell Lymphoma
R-GemOx
Sensitive
:
A2
No biomarker
Mantle Cell Lymphoma
venetoclax + rituximab
Sensitive
:
A2
No biomarker
Mantle Cell Lymphoma
R-CHOP
Sensitive
:
A2
CCR7 positive
Mantle Cell Lymphoma
brexucabtagene autoleucel
Sensitive
:
B
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our